Sodra Alvsborg Hospital-Vastra Gotalandsregionen — Clinical Trial Site

42 Registered trials

18 Currently recruiting

Organisation

Sodra Alvsborg Hospital-Vastra Gotalandsregionen

Location

Boras, Sweden

Identifier

ORG-100029913

Address

Bramhultsvagen 53, Boras Gustav Adolf, 504 55, Sweden

Departments

-
Barn- och Ungdomskliniken, Södra Älvsborgs Sjukhus 504 55 Borås
Barnkliniken SÄS
Dep of Internal Medicine
Department for Gynecology and obstetrics, South Älvsborg Hospital, Brämhultsvägen 53, 510 82 Borås
Department of Oncology
Department of Orthopedics
Diabetesmottagningen, Södra Älvsborgs Sjukhus, Brämhultsvägen 53, 501 82 Borås
Hematolog dagvård
Hematolog dagvård, Brämhultsvägen 53, 501 82 Borås
Hematologi- och onkologiavdelning
Hematologsektionen
Hematology
Hematology day care
Hjartintensivavdelningen
Infektionsenheten, Södra Älvsborgs sjukhus, Samaritvägen 1, Borås
Infektionskliniken
Lungmottagningen
Medicine
Medicinkliniken
Medicinkliniken Hjärtmottagningen
Medicinkliniken, Hematologens Kliniska Provningar, Hiss E plan 7
Medicinkliniken, Hematologens Kliniska Provningar, Hiss E plan 7, 501 82 Borås
Medicinkliniken, Hiss E plan 7
Medicinkliniken/Njursektion
Medicinmottagningen, Södra Älvsborgs Sjukhus Borås
Oncology
ÖNH-mottagning, Södra Älvsborgs sjukhus
Onkologiska kliniken
Onkologkliniken
Onkologmottagning, Södra Älvsborgs Sjukhus
Pediatrik
Rheumatology
SÄS, Medicinkliniken/Hematolog dagvård, Brämhultsvägen 53, 501 82 Borås
Section of Hematology, Dpt of Medicine
Södra Älvsborgs sjukhus, Borås, Kliniska prövningsenheten

Clinical trials at this site (42)

Search interface

Evaluation of the clinical implementation of biofilm susceptibility to antibiotics using Minimum Biofilm Eradication Concentration (MBEC) in… Pending

2024-518350-17-00 Periprosthetic hip joint infection Periprosthetic knee 6
Nordic PREdnisolon for VEstibular NeuriTis Study – an investigator-driven, triple blind, placebo controlled randomized trial Pending

2025-522399-10-00 Vestibular neuritis 5
Tick-Borne Encephalitis (TBE) Remdesivir Efficacy Assessment Trial (TREAT) Pending

2025-523476-23-00 Tick-Borne Encephalitis (TBE) 4
Clinical trial that compares MK-2870 with or without pembrolizumab to chemotherapy in people with breast cancer that cannot be surgically re… Recruiting

2023-504918-29-00 Hormone receptor positive breast cancer 5 2024-08-22
This study is to find out the safety and effectiveness of Epcoritamab together with R-CHOP (rituximab, cyclophosphamide, doxorubicin HCL, vi… Recruiting

2023-505277-32-00 Diffuse Large B-Cell Lymphoma (DLBCL) 5 2023-01-26
Discontinuation Outcome in Multiple Myeloma after BCMA-CD3 treatment Recruiting

2025-524022-18-00 Multiple myeloma 4 2026-05-22
The POWER trial: A randomised, two-armed open label phase 3 clinical trial on personalised dose optimisation with adjuvant tamoxifen therapy… Recruiting

2025-522240-40-00 Breast Cancer 5 2026-03-05
Pivmecillinam as oral step-down treatment for Escherichia coli febrile urinary tract infection versus standard of care; a randomized control… Recruiting

2023-503447-33-00 febrile Urinary Tract Infection (fUTI) 4 2025-11-13
A clinical study of sac-TMT in people with breast cancer (MK-2870-032) Recruiting

2024-520190-12-00 Breast Cancer: triple negative breast cancer (TNBC) and 5 2025-11-10
A Study to Assess Adverse Events and Change in Disease Activity of Oral ABBV-453 Alone or in Combination With Subcutaneous and/or Oral Antim… Recruiting

2024-517140-65-00 Multiple Myeloma (MM). 9 2025-10-23
EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure… Recruiting

2025-521188-11-00 Type 2 diabetes 5 2025-10-15
A clinical phase IV trial to examine cellular and humoral immunity against measles and chickenpox in children and adolescents 0-18 years in … Recruiting

2024-511182-10-01 Pediatric cancer 6 2025-05-22
Clinical trial of MK-2870 in combination with pembrolizumab in people who have had surgery to treat triple negative breast cancer Recruiting

2023-504962-52-00 Triple negative breast cancer. 5 2024-07-10
COMeBAC- COMparison between Bensypenicillin And Cloxacillin treatment in PSSA Recruiting

2023-506860-15-00 Staphylococcus aureus bacteraemia 6 2024-06-11
An international, multicenter, randomised, superiority phase III, open label, 2-arm study to investigate distant metastasis free survival wi… Recruiting

2022-501453-36-00 Breast cancer 5 2024-02-23
Iberdomide Manteinance Versus Lenalidomide Manteinance Therapy Following Autologous Stem Cell Transplant in Participants with NDMM Recruiting

2022-501515-14-00 Newly Diagnosed Multiple Myeloma (NDMM) 5 2023-09-29
A Randomized Trial of Trastuzumab Deruxtecan and Biology-Driven Selection of Neoadjuvant Treatment for HER2-positive Breast Cancer Recruiting

2022-501504-95-00 Non-metastatic HER2-positive Breast Cancer 4 2023-06-23
Alternative antibiotics to multidrug-resistant UTIs Recruiting

2024-513294-41-00 Urinary tract infection and/or bacteremia caused by ext 6 2023-04-17
SACK Recruiting

2022-501600-10-00 Atrial fibrillation and Chronic Kidney Disease stage 5 5 2023-02-07
OPTION – OutPatienT InductiON: Labour induction in an outpatient setting - a multicentre randomized controlled trial Recruiting

2023-507164-39-00 Induction of labour 6 2021-12-01
ProBio: An outcome-adaptive and randomised multi-arm biomarker driven study in patients with metastatic prostate cancer Recruiting

2023-506857-40-00 Prostate Cancer 5 2019-01-08
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change i… Ended

2023-506906-38-00 Follicular Lymphoma 5 2024-05-23
Intralymfatisk immunterapi förstärkt av vitamin-D, en randomiserad placebokontrollerad studie och jämförelse med SLIT Ended

2024-515271-35-00 Allergisk Rinit 10 2023-02-01
SC versus IV isatuximab in combination with pomalidomide and dexamethasone in RRMM Ended

2023-508869-32-00 Cancer - Plasma cell myeloma recurrent 5 2022-11-10